IP Library Granted Patent US 8,123,812
Granted Patent B2
US 8,123,812 · App. 12/583,940 · Granted Feb 28, 2012

Ceramic-ceramic articulation surface implants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,123,812
App. No.
12/583,940
Granted
Feb 28, 2012
Kind
B2
Abstract

A prosthesis for articulation (e.g., hip or joint prosthesis) is provided, which includes a pair of articulation components respectively defining a pair of articulation surfaces movably engageable with each other. In some embodiments, each of the articulation surfaces is formed from a biocompatible ceramic (e.g., doped silicon nitride ceramic) having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (MPam 0.5 ).

Claims (30)

1. A prosthesis for articulation, comprising:

a first component of a joint prosthesis for articulation having a first ceramic articulation surface; and

a second component of the joint prosthesis for articulation having a second ceramic articulation surface for articulation with the first ceramic articulation surface,

wherein at least one of the first ceramic articulation surface and the second ceramic articulation surface comprises biocompatible doped silicon nitride ceramic having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (Mpam 0.5 ), and wherein the doped silicon nitride ceramic comprises one or more dopants selected from the group of dopants consisting of yttrium oxide, magnesium oxide, strontium oxide, and alumina.

2. The prosthesis of claim 1 wherein the biocompatible doped silicon nitride ceramic has a toughness greater than about 9 Mega-Pascal root meter (Mpam 0.5 ).

3. The prosthesis of claim 1 wherein each of the first ceramic articulation surface and the second ceramic articulation surface comprises a biocompatible ceramic having a flexural strength greater than about 700 Mega-Pascal (MPa) and a toughness greater than about 7 Mega-Pascal root meter (Mpam 0.5 ).

4. The prosthesis of claim 1 , wherein the first ceramic articulation surface is generally concave.

5. The prosthesis of claim 4 , wherein the second ceramic articulation surface is generally convex.

6. The prosthesis of claim 1 , wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide.

7. The prosthesis of claim 1 , wherein the biocompatible doped silicon nitride ceramic comprises yttria.

8. The prosthesis of claim 1 , wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide and yttria.

9. The prosthesis of claim 1 wherein the biocompatible doped silicon nitride ceramic does not include strontium oxide.

10. The prosthesis of claim 1 wherein each of the first component and the second component consists essentially of the doped silicon nitride ceramic.

11. The prosthesis of claim 1 , wherein the prosthesis comprises a hip joint prosthesis.

12. The prosthesis of claim 1 , wherein the prosthesis comprises a knee joint prosthesis.

13. The prosthesis of claim 1 , wherein the prosthesis comprises a shoulder joint prosthesis.

14. A prosthesis for articulation, comprising:

a first component of a joint prosthesis for articulation having a first ceramic articulation surface; and

a second component of the joint prosthesis for articulation having a second ceramic articulation surface for articulation with the first ceramic articulation surface,

wherein at least one of the first ceramic articulation surface and the second ceramic articulation surface comprises biocompatible doped silicon nitride ceramic, and wherein the doped silicon nitride ceramic comprises one or more dopants selected from the group of dopants consisting of yttrium oxide, magnesium oxide, strontium oxide, and alumina.

15. The prosthesis of claim 14 , wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide.

16. The prosthesis of claim 14 , wherein the biocompatible doped silicon nitride ceramic comprises yttria.

17. The prosthesis of claim 14 , wherein the biocompatible doped silicon nitride ceramic comprises aluminum oxide and yttria.

18. The prosthesis of claim 14 wherein the biocompatible doped silicon nitride ceramic does not include strontium oxide.

19. The prosthesis of claim 14 wherein each of the first component and the second component consists essentially of the doped silicon nitride ceramic.

20. The prosthesis of claim 14 , wherein the first ceramic articulation surface is generally concave and wherein the second ceramic articulation surface is generally convex.

21. The prosthesis of claim 1 , wherein the biocompatible doped silicon nitride has a flexural strength of between about 700 MPa and 1000 MPa and a fracture toughness of between about 7 MPam 0.5 and 10.5 MPam 0.5 .

22. The prosthesis of claim 21 , wherein each of the first component and the second component comprises the biocompatible doped silicon nitride ceramic.

23. The prosthesis of claim 14 , wherein the biocompatible doped silicon nitride has a flexural strength of between about 700 MPa and 1000 MPa and a fracture toughness of between about 7 MPam 0.5 and 10.5 MPam 0.5 .

24. The prosthesis of claim 21 , wherein each of the first component and the second component comprises the biocompatible doped silicon nitride ceramic.

Assignments (10)
CHANGE OF NAME Recorded Feb 28, 2019
From: AMEDICA CORPORATION
To: SINTX TECHNOLOGIES, INC.
Reel/Frame 048465/0735 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER PREVIOUSLY RECORDED AT REEL: 047199 FRAME: 0313. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Nov 2, 2018
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: AMEDICA CORPORATION; US SPINE, INC.
Reel/Frame 047403/0953 →
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2018
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: AMEDICA CORPORATION; US SPINE, INC.
Reel/Frame 047199/0313 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 029495 FRAME 0211. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNOR: AMEDICA CORPORATION ASSIGNOR: US SPINE, INC. ASSIGNEE: GENERAL ELECTRIC CAPITAL CORPORATION. Recorded Nov 5, 2013
From: AMEDICA CORPORATION; US SPINE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 031581/0831 →
RELEASE OF SECURITY INTEREST Recorded Dec 18, 2012
From: AS COLLATERAL AGENT, KARL KIPKE
To: AMEDICA CORPORATION
Reel/Frame 029491/0851 →
RELEASE OF SECURITY INTEREST Recorded Dec 18, 2012
From: ZIONS FIRST NATIONAL BANK
To: AMEDICA CORPORATION
Reel/Frame 029490/0208 →
SECURITY AGREEMENT Recorded Dec 18, 2012
From: AMEDICA CORPORATION; US SPINE, INC.
To: GE CAPITAL EQUITY INVESTMENTS, INC. C/O GE HEALTHCARE FINANCIAL SERVICES, INC.
Reel/Frame 029495/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2011
From: KHANDKAR, ASHOK C.
To: AMEDICA CORPORATION
Reel/Frame 026931/0761 →
SECURITY AGREEMENT Recorded Mar 4, 2011
From: AMEDICA CORPORATION
To: KARL KIPKE, AS COLLATERAL AGENT
Reel/Frame 025900/0168 →
SECURITY AGREEMENT Recorded Apr 12, 2010
From: AMEDICA CORPORATION
To: ZIONS FIRST NATIONAL BANK
Reel/Frame 024213/0710 →